WASHINGTON, DC—For patients who present with STEMI complicated by cardiogenic shock (STEMI-CS), it’s not news that the long-awaited DanGer Shock trial showed better 180-day survival after Impella CP ...

PARIS, France—Immediate multivessel PCI offers similar survival out to 180 days when compared with culprit-only PCI among STEMI patients with cardiogenic shock, according to provocative new data from ...